Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) FCF Margin: 2022-2023

Historic FCF Margin for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to 28,046.00%.

  • Lexeo Therapeutics' FCF Margin fell 278919.00% to 28,046.00% in Q4 2023 from the same period last year, while for Dec 2023 it was 29,078.54%, marking a year-over-year change of. This contributed to the annual value of 59,585.40% for FY2024, which is 3050686.00% up from last year.
  • Per Lexeo Therapeutics' latest filing, its FCF Margin stood at 28,046.00% for Q4 2023, which was up 4.41% from 26,861.54% recorded in Q3 2023.
  • In the past 5 years, Lexeo Therapeutics' FCF Margin ranged from a high of 36,772.00% in Q1 2023 and a low of 24,969.81% during Q2 2023.
  • In the last 2 years, Lexeo Therapeutics' FCF Margin had a median value of 28,046.00% in 2023 and averaged 29,496.91%.
  • Data for Lexeo Therapeutics' FCF Margin shows a maximum YoY crashed of 278,919bps (in 2023) over the last 5 years.
  • Over the past 2 years, Lexeo Therapeutics' FCF Margin (Quarterly) stood at 30,835.19% in 2022, then slumped by 278,919bps to 28,046.00% in 2023.
  • Its FCF Margin stands at 28,046.00% for Q4 2023, versus 26,861.54% for Q3 2023 and 24,969.81% for Q2 2023.